Clinical Trial Update: Bintrafusp Alfa Program Rollover Study [Phase 3]

View source ↗

Summary

The Phase 3 Bintrafusp alfa rollover study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Lung Cancer, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2026-02-02